2026 is shaping up to be a year where climate investing puts fundamentals over hype: speed, scalability, reliability, and resilience. In that context, Lore De Valck was invited to share biotope’s trend predictions in Climate HardTech’s 2026 Crystal Ball (a roundup of signals from 35 European-focused investors).

Here are the three technology areas we called out:
Synbio for construction
Biology is starting to reshape the built environment—from self-healing concrete to biopolymer coatings and microbial adhesives. The teams most likely to win pair strong science with credible unit economics and high-value, scalable applications.
Encapsulation as an enabling platform
Encapsulation is becoming a quiet powerhouse: improving stability, functionality, and targeted release of bioactives. We’re watching scalable, stimuli-responsive platforms that stay stable from production to shelf life, unlocking applications in nutrition, agriculture, industrial biotech, and beyond.
Biomining for critical metals
As electrification accelerates, demand for metals like copper rises while accessible deposits decline. Biomining is shifting from “nice-to-have sustainable alternative” to potential energy transition infrastructure, especially solutions that reduce chemical use, avoid energy-intensive smelting, and perform on low-grade ores.
More News
The fundraising mirage

Typcal is brewing the future of pragmatic protein

AmphiStar secures €12.5m EIC funding

biotope recap: Summer edition

Annick Verween on the VCo2 podcast

2024 wrapped

Networking with cohort six

B’ZEOS celebrates seed round milestone

Tackling food waste at its source

The value of good mentors

Meet our Spring ‘24 cohort

His son’s allergy turned this father into a founder

FlyBlast: on a mission to solve meat

Biosurfactants from food waste? Meet AmphiStar

Probitat interview

B’ZEOS: sustainable packaging made of seaweed

Elogium: Poultry probiotics for safer food

Launch of Biotope ventures fund

Bolder Foods: non-dairy cheese for a better world

BioVox article

Have you got what it takes?
- Pressure-test your biotech with expert feedback
- Align your team and sharpen your strategy
- Turn your startup into an investment-ready business















































